Impact of an Intensified Thromboprofylaxis Protocol in COVID-19

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
COVID19Thromboembolism
Interventions
OTHER

thromboprofylaxis protocol

This individualised protocol contains three cornerstones: an increase in dosage of prophylactic LMWH close to therapeutic doses, introduction of routine venous ultrasonography and daily measurements of plasma anti-factor Xa activity

OTHER

standard protocol

This protocol contains a routine low dose pharmacological venous thromboembolism (VTE) prophylaxis with LMWH

Trial Locations (1)

3500

Jessa hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER

NCT04394000 - Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 | Biotech Hunter | Biotech Hunter